Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 53.85
+2.20 (4.26%)
Mar 6, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 10.71 billion as of March 6, 2026.
Market Cap
10.71B
Enterprise Value
10.54B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
53.85
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 10.71B, a decrease of -17.45%. That is a compound annual growth rate of -26.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.71B | 5.59% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 15.50B |
| Keymed Biosciences | 14.14B |
| Everest Medicines | 12.51B |
| Guangzhou Innogen Pharmaceutical Group | 10.39B |
| Shanghai Haohai Biological Technology | 9.86B |
| HBM Holdings | 9.76B |
| CStone Pharmaceuticals | 9.47B |
| Abbisko Cayman | 7.62B |